Intensity Modulated Radiotherapy in Head and Neck Cancer: Initial Experience of the First Treated Cases from North-East India

Overview

Journal Indian J Surg Oncol

Specialty Oncology

Date 2023 Oct 30

PMID 37900646

Authors

Jyotiman Nath

Gautam Sarma

Moumita Paul

Mouchumee Bhattacharyya

Apurba Kumar Kalita

Partha Pratim Medhi

Affiliations

Soon will be listed here.

Abstract

Head and neck cancer incidence is relatively higher in north-eastern states than in other parts of India. Intensity-modulated radiotherapy (IMRT) was first introduced in our institute in 2012 to cater the entire north-east. This study attempts to assess the treatment outcomes and prognostic factors of head and neck cancer patients who had been treated with definitive radiotherapy in our institute from 2012 to 2016 using IMRT. This is a single institutional retrospective study. Thirty-six patients of head and neck cancer other than nasopharynx primary treated with definitive radiotherapy using IMRT between 2012 to 2016 were evaluated. The survival was analyzed using the Kaplan-Meir method, and various clinicopathologic factors were compared. The median age of the study patients was 58 years (range 24-79 years). The majority of the patients (69.4%) were below the age of 50 years. Thirty-two patients (88.9%) were male, and only four (11.1%) were females. After a median follow-up time of 40 months (7-84 months), the 5-year overall survival (OS) was 42.1%. The stage at presentation and radiotherapy treatment time were found to be significant prognostic factors of the outcome. The treatment-related toxicities were within acceptable limits. This retrospective study has reported the outcome and treatment-related toxicities of initially treated HNC patients with IMRT from northeast India.

Citing Articles

Comment on: Intensity Modulated Radiotherapy in Head and Neck Cancer: Initial Experience of the First Treated Cases from North-East India.

Topkan E, Somay E, Selek U Indian J Surg Oncol. 2024; 14(4):918-919.

PMID: 38187854 PMC: 10766932. DOI: 10.1007/s13193-023-01804-x.

References

Pericot J, Escriba J, Valdes A, Biosca M, Monner A, Castellsague X . Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx. J Craniomaxillofac Surg. 2000; 28(1):49-55. DOI: 10.1054/jcms.1999.0091. View

Wong Y, Yusof M, Wan Ishak W, Alip A, Ee Phua V . Treatment outcome for head and neck squamous cell carcinoma in a developing country: University Malaya Medical Centre, Malaysia from 2003-2010. Asian Pac J Cancer Prev. 2015; 16(7):2903-8. DOI: 10.7314/apjcp.2015.16.7.2903. View

de Paula A, Souza L, Farias L, Correa G, Fraga C, Eleuterio N . Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009; 45(9):777-82. DOI: 10.1016/j.oraloncology.2008.11.015. View

Mohanti B, Nachiappan P, Pandey R, Sharma A, Bahadur S, Thakar A . Analysis of 2167 head and neck cancer patients' management, treatment compliance and outcomes from a regional cancer centre, Delhi, India. J Laryngol Otol. 2006; 121(1):49-56. DOI: 10.1017/S0022215106002751. View

Nutting C, Morden J, Harrington K, Urbano T, Bhide S, Clark C . Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011; 12(2):127-36. PMC: 3033533. DOI: 10.1016/S1470-2045(10)70290-4. View

Pruegsanusak K, Peeravut S, Leelamanit V, Sinkijcharoenchai W, Jongsatitpaiboon J, Phungrassami T . Survival and prognostic factors of different sites of head and neck cancer: an analysis from Thailand. Asian Pac J Cancer Prev. 2012; 13(3):885-90. DOI: 10.7314/apjcp.2012.13.3.885. View

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

Barzan L, Talamini R, Franchin G, Vaccher E, Politi D, Minatel E . Changes in presentation and survival of head and neck carcinomas in Northeastern Italy, 1975-1998. Cancer. 2002; 95(3):540-52. DOI: 10.1002/cncr.10682. View

Adelstein D, Li Y, Adams G, Wagner Jr H, Kish J, Ensley J . An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2002; 21(1):92-8. DOI: 10.1200/JCO.2003.01.008. View

10.

Gregoire V, Coche E, Cosnard G, Hamoir M, Reychler H . Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol. 2000; 56(2):135-50. DOI: 10.1016/s0167-8140(00)00202-4. View

11.

Loimu V, Collan J, Vaalavirta L, Back L, Kapanen M, Makitie A . Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin. Radiother Oncol. 2010; 98(1):34-7. DOI: 10.1016/j.radonc.2010.10.015. View

12.

Pignon J, Le Maitre A, Maillard E, Bourhis J . Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009; 92(1):4-14. DOI: 10.1016/j.radonc.2009.04.014. View

13.

Datta S, Chaturvedi P, Mishra A, Pawar P . A review of Indian literature for association of smokeless tobacco with malignant and premalignant diseases of head and neck region. Indian J Cancer. 2014; 51(3):200-208. DOI: 10.4103/0019-509X.146713. View

14.

Rathod S, Gupta T, Ghosh-Laskar S, Murthy V, Budrukkar A, Agarwal J . Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective.... Oral Oncol. 2013; 49(6):634-42. DOI: 10.1016/j.oraloncology.2013.02.013. View

15.

Shaikh T, Handorf E, Murphy C, Mehra R, Ridge J, Galloway T . The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016; 96(5):967-975. PMC: 5147736. DOI: 10.1016/j.ijrobp.2016.08.046. View

16.

MacKenzie R, Franssen E, Balogh J, Gilbert R, Birt D, Davidson J . Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys. 2000; 47(1):65-71. DOI: 10.1016/s0360-3016(00)00415-6. View

17.

Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S . Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol. 2012; 104(3):343-8. DOI: 10.1016/j.radonc.2012.07.001. View

18.

Lacas B, Carmel A, Landais C, Wong S, Licitra L, Tobias J . Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group. Radiother Oncol. 2021; 156:281-293. PMC: 8386522. DOI: 10.1016/j.radonc.2021.01.013. View

19.

Mackenzie K, Savage S, Birchall M . Processes and outcomes of head and neck cancer patients from geographically disparate regions of the UK. A comparison of Scottish and English cohorts. Eur J Surg Oncol. 2009; 35(10):1113-8. DOI: 10.1016/j.ejso.2009.04.001. View

20.

Ghosh-Laskar S, Yathiraj P, Dutta D, Rangarajan V, Purandare N, Gupta T . Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results. Head Neck. 2015; 38 Suppl 1:E1481-7. DOI: 10.1002/hed.24263. View